SciBrunch

KyDo

This biotechnology company develops small molecule inhibitors for the treatment of cancer variants in oncology patients.

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.

Signase

This biotechnology company develops small molecule inhibitors of cell replication pathways to treat cancer patients by inhibiting tumour growth.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

Bioarchitech

This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.